Search Results 91-100 of 14966 for Break STD Taboo
... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...
A Study to Compare the Effectiveness and Safety of bb2121 Versus Standard Regimens in Subjects with Relapsed and Refractory Multiple Myeloma (RRMM) · Share ...
This trial incorporates both a novel up front GVHD therapy (sirolimus) as well as a novel BMT CTN developed acute GVHD biomarker test. Participation eligibility.
The objective of this study is to collect data using wearable biosensors from standard of care patients toward the development of an algorithm that can estimate ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.